EMBO awards Installation Grants to ten life scientists to set up laboratories in Czech Republic, Estonia, Poland, Portugal and Turkey

Posted on 14, December 2016 by | This entry was posted in Financial, Germany, Healthcare, Science, Technology and tagged , , , , , , , , , . Bookmark the permalink.

HEIDELBERG, 14-Dec-2016 — /EuropaWire/ — Ten life scientists have been awarded EMBO Installation Grants to set up independent research laboratories in the Czech Republic, Estonia, Poland, Portugal and Turkey.

“Through the Installation Grants we encourage some of the best early-career researchers to share their expertise across Europe by setting up laboratories in selected EMBC Member States,” explains EMBO Director Maria Leptin. “Each year, we receive applications from outstanding scientists, and it is a pleasure to be able to support them during this challenging career phase in order to establish scientific excellence across the whole continent.”

Installation Grants are awarded annually. They are funded primarily by the participating member states Czech Republic, Estonia, Poland, Portugal and Turkey. Grantees are selected by a committee of EMBO Members on the basis scientific excellence as the primary selection criterion.

Each Installation Grantee receives 50,000 euros annually for three to five years to support the establishment of an independent research group. In addition to financial support, the recipients receive networking opportunities and practical support by becoming part of the EMBO Young Investigator network.

Since 2006, EMBO has supported 89 group leaders through Installation Grants. Of the most recent awardees, four will establish laboratories in Turkey, two in Poland, two in Portugal, one in Estonia, and one in the Czech Republic.

The next application deadline for EMBO Installation Grants is 15 April 2017.

NameResearch interestGoing toComing from
Melih AcarHematopoietic stem cell regulationBahcesehir University, School of Medicine, Istanbul, TRUT Southwestern Medical Center, Dallas, TX, US
Jaan-Olle AndressooGene knock-up to treat Parkinson’s diseaseTallinn Institute of Technology, EEUniversity of Helsinki, FI
Claus Maria AzzalinTelomeres, cancer and agingInstitute of Molecular Medicine, Lisbon, PTInstitute of Biochemistry, ETH Zurich, CH
Murat Alper CevherCharacterization of mediator-estrogen receptor interactionBilkent University, Ankara, TRRockefeller University, NY, US
Rafal CioskCell fate plasticity in development and tissue homeostasisInstitute of Bioorganic Chemistry, Poznan, PLFriedrich Miescher Institute for Biomedical Research, Basel, CH
Elif Nur Firat-KaralarFunction and regulation of the centrosome/cilium complexKoç University, Istanbul, TRStanford University, CA, USA
Catarina HomemTemporal and metabolic regulation of stem cellsChronic Diseases Research Center, Nova Medical School, PTInstitute of Molecular Biotechnology of Austria, Vienna, AT
Abdullah KahramanNon-coding cancer driver mutations in isoform networksSabanci University, Istanbul, TRInstitute of Molecular Life Sciences, University of Zurich, CH
Vladimír VargaConstruction of the eukaryotic flagellumInstitute of Molecular Genetics of the ASCR, Prague, CZUniversity of Oxford, UK
Piotr ZiolkowskiCrossover control in plantsAdam Mickiewicz University, Poznan, PLUniversity of Cambridge, Cambridge, UK

SOURCE: EMBO

PRESS CONTACT
communications@embo.org

Tilmann KiesslingTilmann Kiessling
Head, Communications
T. + 49 160 9019 3839

Follow EuropaWire on Google News
EDITOR'S PICK:

Comments are closed.